Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test.
Sluimer, John Goderski, Gabriel van den Brink, Sharon Broeders, Maaike Rahamat-Langendoen, Janette Then, Euníce Wijsman, Lisa Wolters, Femke van de Bovenkamp, Jeroen Melchers, Willem Jg
Sluimer, John
Goderski, Gabriel
van den Brink, Sharon
Broeders, Maaike
Rahamat-Langendoen, Janette
Then, Euníce
Wijsman, Lisa
Wolters, Femke
van de Bovenkamp, Jeroen
Melchers, Willem Jg
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2021-09-24
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Multi-center evaluation of Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV molecular point-of-care test.
Translated Title
Published in
Journal of clinical virology plus 2022;1(4):100042
Abstract
The Xpert® Xpress SARS-CoV-2/Flu/RSV assay was compared to three reference assays at three Dutch medical microbiology laboratories. An external quality assessment panel consisting of 16 specimens containing SARS-CoV-2, influenza viruses, RSV or human seasonal coronaviruses, or a combination thereof were used. Clinical specimens containing SARS-CoV-2 (n = 57), influenza viruses (n = 21) or RSV (n = 12), at a wide range of relevant concentrations were used. One laboratory also tested zoonotic avian and swine influenza viruses, and eight relevant SARS-CoV-2 variants.